ESTIMATED COSTS OF HER2-POSITIVE METASTATIC BREAST CANCER FOR PATIENTS INITIATING AN ORAL ANTICANCER TREATMENT- RESULTS FROM A FRENCH PROSPECTIVE OBSERVATIONAL STUDY
Abstract
Authors
M.C. Woronoff-Lemsi C. Chaix-Couturier I. Durand-Zaleski M. Espié A. Lortholary Y. Merrouche A. Flinois H. Chabernaud L. Benjamin